Most lately, it has been determined that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in similar spots as classical opioid receptors, it binds to a big range of endogenous opioids. Unlike most opioid receptors, this receptor functions for a scavenger and does not activate a 2nd messenger proced… Read More